Supplementary Figure 4 from Enhancement of Synthetic Lethality via Combinations of ABT-888, a PARP Inhibitor, and Carboplatin In Vitro and In Vivo Using BRCA1 and BRCA2 Isogenic Models
Year: 2023
Type: supplementary-materials
Abstract: PDF file, 371K, SUPPLEMENTARY FIGURE S4. Hematoxylin and Eosin staining (200x magnification) of tumor sections.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362481359